AIM
PACB icon

ARK Investment Management’s Pacific Biosciences PACB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$45M Sell
36,298,163
-180,278
-0.5% -$224K 0.33% 50
2025
Q1
$43M Buy
36,478,441
+434,079
+1% +$512K 0.43% 43
2024
Q4
$66M Buy
36,044,362
+2,637,961
+8% +$4.83M 0.55% 35
2024
Q3
$56.8M Buy
33,406,401
+193,947
+0.6% +$330K 0.52% 36
2024
Q2
$45.5M Sell
33,212,454
-77,683
-0.2% -$106K 0.4% 41
2024
Q1
$125M Sell
33,290,137
-1,214,136
-4% -$4.55M 0.86% 31
2023
Q4
$338M Buy
34,504,273
+4,681,833
+16% +$45.9M 2% 17
2023
Q3
$249M Buy
29,822,440
+3,187,820
+12% +$26.6M 1.91% 18
2023
Q2
$354M Sell
26,634,620
-1,119,059
-4% -$14.9M 2.35% 16
2023
Q1
$321M Buy
27,753,679
+2,061,998
+8% +$23.9M 2.21% 17
2022
Q4
$210M Sell
25,691,681
-3,000,813
-10% -$24.5M 1.82% 20
2022
Q3
$167M Buy
28,692,494
+646,964
+2% +$3.76M 1.16% 23
2022
Q2
$158M Buy
28,045,530
+786,009
+3% +$4.43M 0.93% 27
2022
Q1
$248M Buy
27,259,521
+876,418
+3% +$7.98M 1.04% 26
2021
Q4
$540M Buy
26,383,103
+3,660,028
+16% +$74.9M 1.63% 20
2021
Q3
$581M Buy
22,723,075
+2,241,589
+11% +$57.3M 1.39% 22
2021
Q2
$716M Sell
20,481,486
-819,705
-4% -$28.7M 1.33% 23
2021
Q1
$710M Sell
21,301,191
-7,203,438
-25% -$240M 1.41% 17
2020
Q4
$739M Buy
28,504,629
+8,659,849
+44% +$225M 1.97% 11
2020
Q3
$196M Buy
19,844,780
+11,613,288
+141% +$115M 1.16% 28
2020
Q2
$28.4M Buy
8,231,492
+4,038,433
+96% +$13.9M 0.31% 51
2020
Q1
$12.8M Buy
4,193,059
+2,683,645
+178% +$8.21M 0.32% 51
2019
Q4
$7.76M Buy
1,509,414
+752,617
+99% +$3.87M 0.2% 65
2019
Q3
$3.91M Buy
+756,797
New +$3.91M 0.09% 82
2019
Q2
Hold
0
211
2019
Q1
Sell
-590
Closed -$4K 198
2018
Q4
$4K Sell
590
-7,785,895
-100% -$52.8M ﹤0.01% 194
2018
Q3
$42.1M Buy
7,786,485
+1,465,192
+23% +$7.93M 1.27% 30
2018
Q2
$22.4M Buy
6,321,293
+2,036,596
+48% +$7.23M 0.82% 37
2018
Q1
$8.78M Buy
4,284,697
+4,070,780
+1,903% +$8.35M 0.44% 53
2017
Q4
$565K Buy
213,917
+179,192
+516% +$473K 0.05% 114
2017
Q3
$182K Buy
+34,725
New +$182K 0.02% 121